SCHEMBL14728209

SCHEMBL14728209

CC(C)(C)OC(=O)C(Br)Cc1ccc(O[Si](C)(C)C(C)(C)C)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PREP P48147 4/20 0.39
CA12 O43570 4/20 0.39
CA1 P00915 4/20 0.39
CA9 Q16790 4/20 0.39
ADRB3 P13945 1/20 0.37
ITGB3 P05106 1/20 0.37
ITGA2B P08514 1/20 0.37
LDHA P00338 1/20 0.36
ATM Q13315 1/20 0.34
ITGA4 P13612 1/20 0.34
ITGB7 P26010 1/20 0.34
DRD2 P14416 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
NPR3 P17342 1/20 0.34
LMNA P02545 1/20 0.34
KMT2A Q03164 1/20 0.34
ACACB O00763 1/20 0.34
CTSS P25774 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14728212 0.86 LDHA (0.44) PREPCA12CA1CA9ITGB3
SCHEMBL14728208 0.83 LTA4H (0.44) PREPADRB3ITGB3ITGA2BATM
SCHEMBL10656495 0.79 ATM (0.51) CA12CA1ATMITGA4ITGB7
SCHEMBL642059 0.79 ATM (0.51) CA12CA1ATMITGA4ITGB7
SCHEMBL28736964 0.79 ITGB3 (0.47) ITGB3ITGA2BATMACACBCTSS
SCHEMBL28736965 0.79 ITGB3 (0.47) ITGB3ITGA2BATMACACBCTSS
SCHEMBL20437145 0.79 ITGB3 (0.52) ITGB3ITGA2BITGA4ITGB7LMNA
SCHEMBL9848674 0.78 CYP1A2 (0.47) PREPCA12CA1CA9LDHA
SCHEMBL13080680 0.78 PREP (0.42) PREPCA12CA1CA9LDHA
SCHEMBL7588471 0.78 PREP (0.42) PREPCA12CA1CA9ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230131121-A1 BRANCHED DISCRETE PEG CONSTRUCTS AUDAX PRIVATE DEBT LLC, AS AGENT 2023-04-27 US disclosed
US-20170313656-A1 Branched Discrete PEG Constructs QUANTA BIODESIGN, LTD. 2017-11-02 US disclosed
US-20150065711-A1 Discrete PEG Constructs EQUIP, LLC (US) 2015-03-05 US disclosed
US-20130052130-A1 Branched Discreet PEG Constructs UNIVERSITY OF WASHINGTON (US) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170313656-A1 Branched Discrete PEG Constructs BTD, IDUA, DNPEP PREP 179/4885CA12 130/4885CA1 1425/4885
US-20150065711-A1 Discrete PEG Constructs MUC1, EGFR, LNPEP PREP 817/4885CA12 712/4885CA1 2212/4885
US-20230131121-A1 BRANCHED DISCRETE PEG CONSTRUCTS BTD, IDUA, DNPEP PREP 160/4885CA12 132/4885CA1 1416/4885
US-20130052130-A1 Branched Discreet PEG Constructs BTD, DNPEP, IDUA PREP 102/4885CA12 91/4885CA1 1384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.